Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), has amended the terms of its previously announced bought deal financing.
Under the amended terms, a syndicate of underwriters led by Canaccord Genuity (OTCPK:CCORF) and BMO Capital Markets, have agreed to buy on a bought deal basis 61.2 million units of the company, at a price of $2.45 per unit for gross proceeds of approximately $150 million. Each unit will be comprised of one common share of the company and one common share purchase warrant of the company.
